Results 231 to 240 of about 96,540 (304)

Runtime Monitoring of Static Fairness Properties

open access: yes
Henzinger TA   +3 more
europepmc   +1 more source

Biceps‐Augmented Reverse Remplissage for Filling of Reverse Hill‐Sachs Defects

open access: yesArthroscopy Techniques, EarlyView.
Abstract Reverse Hill‐Sachs lesions pose a complex challenge in the management of posterior shoulder dislocations. These lesions complicate surgical management as a result of their association with recurrent instability and further joint destruction.
Mohamed Gamal Morsy   +2 more
wiley   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova   +5 more
wiley   +1 more source

Certified randomness using a trapped-ion quantum processor. [PDF]

open access: yesNature
Liu M   +31 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy